McCall Mariposa, Bourgeois James A
Department of Psychiatry and Behavioral Sciences, University of California, Davis Medical Center, Sacramento, CA 95817, USA.
J Clin Psychopharmacol. 2004 Oct;24(5):521-6. doi: 10.1097/01.jcp.0000138768.61600.ad.
The authors present a case of a patient treated with valproic acid for seizure disorder who presented with acute mental status changes consistent with encephalopathy. Notably, her serum ammonia level was 3 times the upper limit of normal, despite an only mildly elevated aspartate aminotransferase and normal bilirubin. Her serum valproic acid level was in the therapeutic range. Her symptoms resolved with discontinuation of valproic acid and supportive care. The authors review the possible mechanisms of valproic acid-associated hyperammonemia with encephalopathy and propose clinical practice modifications to minimize the incidence of this adverse reaction to this generally well-tolerated and clinically important psychotropic medication.
作者报告了一例因癫痫障碍接受丙戊酸治疗的患者,该患者出现了与脑病相符的急性精神状态改变。值得注意的是,尽管其天冬氨酸转氨酶仅轻度升高且胆红素正常,但她的血清氨水平是正常上限的3倍。她的血清丙戊酸水平处于治疗范围内。停用丙戊酸并给予支持性治疗后,她的症状得到缓解。作者回顾了丙戊酸相关高氨血症伴脑病的可能机制,并提出了临床实践改进措施,以尽量减少对这种通常耐受性良好且具有临床重要性的精神药物的这种不良反应的发生率。